報價延遲最少15分鐘:2024/11/10 17:11 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
10.85 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.02/0.18
|
|
企業價值
176.03M
|
| 資產負債 |
|
每股賬面淨值
2.58
|
| 現金流量 |
|
現金流量率
0.05
|
| 損益表 |
|
收益
31.79M
|
|
每股收益
1.44
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/11/10 17:11 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems. |